339 related articles for article (PubMed ID: 27514671)
1. Imaging biomarkers for steatohepatitis and fibrosis detection in non-alcoholic fatty liver disease.
Gallego-Durán R; Cerro-Salido P; Gomez-Gonzalez E; Pareja MJ; Ampuero J; Rico MC; Aznar R; Vilar-Gomez E; Bugianesi E; Crespo J; González-Sánchez FJ; Aparcero R; Moreno I; Soto S; Arias-Loste MT; Abad J; Ranchal I; Andrade RJ; Calleja JL; Pastrana M; Iacono OL; Romero-Gómez M
Sci Rep; 2016 Aug; 6():31421. PubMed ID: 27514671
[TBL] [Abstract][Full Text] [Related]
2. MR elastography is effective for the non-invasive evaluation of fibrosis and necroinflammatory activity in patients with nonalcoholic fatty liver disease.
Costa-Silva L; Ferolla SM; Lima AS; Vidigal PVT; Ferrari TCA
Eur J Radiol; 2018 Jan; 98():82-89. PubMed ID: 29279175
[TBL] [Abstract][Full Text] [Related]
3. Multiparametric magnetic resonance imaging for the assessment of non-alcoholic fatty liver disease severity.
Pavlides M; Banerjee R; Tunnicliffe EM; Kelly C; Collier J; Wang LM; Fleming KA; Cobbold JF; Robson MD; Neubauer S; Barnes E
Liver Int; 2017 Jul; 37(7):1065-1073. PubMed ID: 27778429
[TBL] [Abstract][Full Text] [Related]
4. Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography.
Imajo K; Kessoku T; Honda Y; Tomeno W; Ogawa Y; Mawatari H; Fujita K; Yoneda M; Taguri M; Hyogo H; Sumida Y; Ono M; Eguchi Y; Inoue T; Yamanaka T; Wada K; Saito S; Nakajima A
Gastroenterology; 2016 Mar; 150(3):626-637.e7. PubMed ID: 26677985
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of the index of NASH - ION for the diagnosis of steatohepatitis in patients with non-alcoholic fatty liver: An external validation study.
Younes R; Rosso C; Petta S; Cucco M; Marietti M; Caviglia GP; Ciancio A; Abate ML; Cammà C; Smedile A; Craxì A; Saracco GM; Bugianesi E
Liver Int; 2018 Apr; 38(4):715-723. PubMed ID: 29028281
[TBL] [Abstract][Full Text] [Related]
6. Shear Wave Elastography for Assessment of Steatohepatitis and Hepatic Fibrosis in Rat Models of Non-Alcoholic Fatty Liver Disease.
Kang BK; Lee SS; Cheong H; Hong SM; Jang K; Lee MG
Ultrasound Med Biol; 2015 Dec; 41(12):3205-15. PubMed ID: 26349582
[TBL] [Abstract][Full Text] [Related]
7. Assessment of Nonalcoholic Fatty Liver Disease in Rats Using Quantitative Dynamic Contrast-Enhanced MRI.
Wu Z; Cheng ZL; Yi ZL; Xie MW; Zeng H; Lu LJ; Xu X; Shen J
J Magn Reson Imaging; 2017 May; 45(5):1485-1493. PubMed ID: 27606822
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic value of MR-based texture analysis for the assessment of hepatic fibrosis in patients with nonalcoholic fatty liver disease (NAFLD).
Cannella R; Borhani AA; Tublin M; Behari J; Furlan A
Abdom Radiol (NY); 2019 May; 44(5):1816-1824. PubMed ID: 30788556
[TBL] [Abstract][Full Text] [Related]
9. Multiparametric MR Index for the Diagnosis of Non-Alcoholic Steatohepatitis in Patients with Non-Alcoholic Fatty Liver Disease.
Kim JW; Lee YS; Park YS; Kim BH; Lee SY; Yeon JE; Lee CH
Sci Rep; 2020 Feb; 10(1):2671. PubMed ID: 32060386
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic value of MRI-derived liver surface nodularity score for the non-invasive quantification of hepatic fibrosis in non-alcoholic fatty liver disease.
Catania R; Furlan A; Smith AD; Behari J; Tublin ME; Borhani AA
Eur Radiol; 2021 Jan; 31(1):256-263. PubMed ID: 32757050
[TBL] [Abstract][Full Text] [Related]
11. Serum cytokeratin-18 fragment levels as noninvasive marker of nonalcoholic steatohepatitis in the chilean population.
Arab JP; Hernández-Rocha C; Morales C; Vargas JI; Solís N; Pizarro M; Robles C; Sandoval D; Ponthus S; Benítez C; Barrera F; Soza A; Riquelme A; Arrese M
Gastroenterol Hepatol; 2017; 40(6):388-394. PubMed ID: 28359548
[TBL] [Abstract][Full Text] [Related]
12. Performance of unidimensional transient elastography in staging non-alcoholic steatohepatitis.
Lupsor M; Badea R; Stefanescu H; Grigorescu M; Serban A; Radu C; Crişan D; Sparchez Z; Iancu S; Maniu A
J Gastrointestin Liver Dis; 2010 Mar; 19(1):53-60. PubMed ID: 20361076
[TBL] [Abstract][Full Text] [Related]
13. Liver surface nodularity on non-contrast MRI identifies advanced fibrosis in patients with NAFLD.
Dioguardi Burgio M; Sartoris R; Beaufrere A; Grégory J; Guiu B; Guillot C; Rautou PE; Castera L; Bouattour M; Paradis V; Vilgrain V; Ronot M
Eur Radiol; 2022 Mar; 32(3):1781-1791. PubMed ID: 34533606
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology and natural history of non-alcoholic fatty liver disease.
Fazel Y; Koenig AB; Sayiner M; Goodman ZD; Younossi ZM
Metabolism; 2016 Aug; 65(8):1017-25. PubMed ID: 26997539
[TBL] [Abstract][Full Text] [Related]
15. Contrast-enhanced ultrasonography could be a non-invasive method for differentiating none or mild from severe fibrosis in patients with biopsy proven non-alcoholic fatty liver disease.
Nasr P; Hilliges A; Thorelius L; Kechagias S; Ekstedt M
Scand J Gastroenterol; 2016 Sep; 51(9):1126-32. PubMed ID: 27161854
[TBL] [Abstract][Full Text] [Related]
16. MRE combined with FIB-4 (MEFIB) index in detection of candidates for pharmacological treatment of NASH-related fibrosis.
Jung J; Loomba RR; Imajo K; Madamba E; Gandhi S; Bettencourt R; Singh S; Hernandez C; Valasek MA; Behling C; Richards L; Fowler K; Sirlin CB; Nakajima A; Loomba R
Gut; 2021 Oct; 70(10):1946-1953. PubMed ID: 33214165
[TBL] [Abstract][Full Text] [Related]
17. FICK-3 Score Combining Fibrosis-4, Insulin Resistance and Cytokeratin-18 in Predicting Non-alcoholic Steatohepatitis in NAFLD Egyptian Patients.
Mohammed MA; Omar NM; Mohammed SA; Amin AM; Gad DF
Pak J Biol Sci; 2019 Jan; 22(10):457-466. PubMed ID: 31930835
[TBL] [Abstract][Full Text] [Related]
18. Quantitative multiparametric magnetic resonance imaging can aid non-alcoholic steatohepatitis diagnosis in a Japanese cohort.
Imajo K; Tetlow L; Dennis A; Shumbayawonda E; Mouchti S; Kendall TJ; Fryer E; Yamanaka S; Honda Y; Kessoku T; Ogawa Y; Yoneda M; Saito S; Kelly C; Kelly MD; Banerjee R; Nakajima A
World J Gastroenterol; 2021 Feb; 27(7):609-623. PubMed ID: 33642832
[TBL] [Abstract][Full Text] [Related]
19. Predictive value of ALT levels for non-alcoholic steatohepatitis (NASH) and advanced fibrosis in non-alcoholic fatty liver disease (NAFLD).
Verma S; Jensen D; Hart J; Mohanty SR
Liver Int; 2013 Oct; 33(9):1398-405. PubMed ID: 23763360
[TBL] [Abstract][Full Text] [Related]
20. Imaging biomarkers of NAFLD, NASH, and fibrosis.
Ajmera V; Loomba R
Mol Metab; 2021 Aug; 50():101167. PubMed ID: 33460786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
